Image-based multiplex immune profiling of cancer tissues : translational implications. A report of the International Immuno-oncology Biomarker Working Group on Breast Cancer
© 2024 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland..
Recent advances in the field of immuno-oncology have brought transformative changes in the management of cancer patients. The immune profile of tumours has been found to have key value in predicting disease prognosis and treatment response in various cancers. Multiplex immunohistochemistry and immunofluorescence have emerged as potent tools for the simultaneous detection of multiple protein biomarkers in a single tissue section, thereby expanding opportunities for molecular and immune profiling while preserving tissue samples. By establishing the phenotype of individual tumour cells when distributed within a mixed cell population, the identification of clinically relevant biomarkers with high-throughput multiplex immunophenotyping of tumour samples has great potential to guide appropriate treatment choices. Moreover, the emergence of novel multi-marker imaging approaches can now provide unprecedented insights into the tumour microenvironment, including the potential interplay between various cell types. However, there are significant challenges to widespread integration of these technologies in daily research and clinical practice. This review addresses the challenges and potential solutions within a structured framework of action from a regulatory and clinical trial perspective. New developments within the field of immunophenotyping using multiplexed tissue imaging platforms and associated digital pathology are also described, with a specific focus on translational implications across different subtypes of cancer. © 2024 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:262 |
|---|---|
| Enthalten in: |
The Journal of pathology - 262(2024), 3 vom: 01. März, Seite 271-288 |
| Sprache: |
Englisch |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 06.02.2024 Date Revised 04.04.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1002/path.6238 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM36720990X |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM36720990X | ||
| 003 | DE-627 | ||
| 005 | 20240404234618.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240117s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/path.6238 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1364.xml |
| 035 | |a (DE-627)NLM36720990X | ||
| 035 | |a (NLM)38230434 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Jahangir, Chowdhury Arif |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Image-based multiplex immune profiling of cancer tissues |b translational implications. A report of the International Immuno-oncology Biomarker Working Group on Breast Cancer |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 06.02.2024 | ||
| 500 | |a Date Revised 04.04.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2024 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland. | ||
| 520 | |a Recent advances in the field of immuno-oncology have brought transformative changes in the management of cancer patients. The immune profile of tumours has been found to have key value in predicting disease prognosis and treatment response in various cancers. Multiplex immunohistochemistry and immunofluorescence have emerged as potent tools for the simultaneous detection of multiple protein biomarkers in a single tissue section, thereby expanding opportunities for molecular and immune profiling while preserving tissue samples. By establishing the phenotype of individual tumour cells when distributed within a mixed cell population, the identification of clinically relevant biomarkers with high-throughput multiplex immunophenotyping of tumour samples has great potential to guide appropriate treatment choices. Moreover, the emergence of novel multi-marker imaging approaches can now provide unprecedented insights into the tumour microenvironment, including the potential interplay between various cell types. However, there are significant challenges to widespread integration of these technologies in daily research and clinical practice. This review addresses the challenges and potential solutions within a structured framework of action from a regulatory and clinical trial perspective. New developments within the field of immunophenotyping using multiplexed tissue imaging platforms and associated digital pathology are also described, with a specific focus on translational implications across different subtypes of cancer. © 2024 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Research Support, N.I.H., Extramural | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a cancer prognosis | |
| 650 | 4 | |a clinical integration | |
| 650 | 4 | |a digital image analysis | |
| 650 | 4 | |a multiplex imaging | |
| 650 | 4 | |a multiplex immunofluorescence | |
| 650 | 4 | |a multiplex immunohistochemistry | |
| 650 | 4 | |a therapy response | |
| 650 | 4 | |a tumour immune profiling | |
| 650 | 4 | |a tumour infiltrating lymphocytes | |
| 650 | 7 | |a Biomarkers, Tumor |2 NLM | |
| 700 | 1 | |a Page, David B |e verfasserin |4 aut | |
| 700 | 1 | |a Broeckx, Glenn |e verfasserin |4 aut | |
| 700 | 1 | |a Gonzalez, Claudia A |e verfasserin |4 aut | |
| 700 | 1 | |a Burke, Caoimbhe |e verfasserin |4 aut | |
| 700 | 1 | |a Murphy, Clodagh |e verfasserin |4 aut | |
| 700 | 1 | |a Reis-Filho, Jorge S |e verfasserin |4 aut | |
| 700 | 1 | |a Ly, Amy |e verfasserin |4 aut | |
| 700 | 1 | |a Harms, Paul W |e verfasserin |4 aut | |
| 700 | 1 | |a Gupta, Rajarsi R |e verfasserin |4 aut | |
| 700 | 1 | |a Vieth, Michael |e verfasserin |4 aut | |
| 700 | 1 | |a Hida, Akira I |e verfasserin |4 aut | |
| 700 | 1 | |a Kahila, Mohamed |e verfasserin |4 aut | |
| 700 | 1 | |a Kos, Zuzana |e verfasserin |4 aut | |
| 700 | 1 | |a van Diest, Paul J |e verfasserin |4 aut | |
| 700 | 1 | |a Verbandt, Sara |e verfasserin |4 aut | |
| 700 | 1 | |a Thagaard, Jeppe |e verfasserin |4 aut | |
| 700 | 1 | |a Khiroya, Reena |e verfasserin |4 aut | |
| 700 | 1 | |a Abduljabbar, Khalid |e verfasserin |4 aut | |
| 700 | 1 | |a Acosta Haab, Gabriela |e verfasserin |4 aut | |
| 700 | 1 | |a Acs, Balazs |e verfasserin |4 aut | |
| 700 | 1 | |a Adams, Sylvia |e verfasserin |4 aut | |
| 700 | 1 | |a Almeida, Jonas S |e verfasserin |4 aut | |
| 700 | 1 | |a Alvarado-Cabrero, Isabel |e verfasserin |4 aut | |
| 700 | 1 | |a Azmoudeh-Ardalan, Farid |e verfasserin |4 aut | |
| 700 | 1 | |a Badve, Sunil |e verfasserin |4 aut | |
| 700 | 1 | |a Baharun, Nurkhairul Bariyah |e verfasserin |4 aut | |
| 700 | 1 | |a Bellolio, Enrique R |e verfasserin |4 aut | |
| 700 | 1 | |a Bheemaraju, Vydehi |e verfasserin |4 aut | |
| 700 | 1 | |a Blenman, Kim Rm |e verfasserin |4 aut | |
| 700 | 1 | |a Botinelly Mendonça Fujimoto, Luciana |e verfasserin |4 aut | |
| 700 | 1 | |a Burgues, Octavio |e verfasserin |4 aut | |
| 700 | 1 | |a Chardas, Alexandros |e verfasserin |4 aut | |
| 700 | 1 | |a Cheang, Maggie Chon U |e verfasserin |4 aut | |
| 700 | 1 | |a Ciompi, Francesco |e verfasserin |4 aut | |
| 700 | 1 | |a Cooper, Lee Ad |e verfasserin |4 aut | |
| 700 | 1 | |a Coosemans, An |e verfasserin |4 aut | |
| 700 | 1 | |a Corredor, Germán |e verfasserin |4 aut | |
| 700 | 1 | |a Dantas Portela, Flavio Luis |e verfasserin |4 aut | |
| 700 | 1 | |a Deman, Frederik |e verfasserin |4 aut | |
| 700 | 1 | |a Demaria, Sandra |e verfasserin |4 aut | |
| 700 | 1 | |a Dudgeon, Sarah N |e verfasserin |4 aut | |
| 700 | 1 | |a Elghazawy, Mahmoud |e verfasserin |4 aut | |
| 700 | 1 | |a Fernandez-Martín, Claudio |e verfasserin |4 aut | |
| 700 | 1 | |a Fineberg, Susan |e verfasserin |4 aut | |
| 700 | 1 | |a Fox, Stephen B |e verfasserin |4 aut | |
| 700 | 1 | |a Giltnane, Jennifer M |e verfasserin |4 aut | |
| 700 | 1 | |a Gnjatic, Sacha |e verfasserin |4 aut | |
| 700 | 1 | |a Gonzalez-Ericsson, Paula I |e verfasserin |4 aut | |
| 700 | 1 | |a Grigoriadis, Anita |e verfasserin |4 aut | |
| 700 | 1 | |a Halama, Niels |e verfasserin |4 aut | |
| 700 | 1 | |a Hanna, Matthew G |e verfasserin |4 aut | |
| 700 | 1 | |a Harbhajanka, Aparna |e verfasserin |4 aut | |
| 700 | 1 | |a Hart, Steven N |e verfasserin |4 aut | |
| 700 | 1 | |a Hartman, Johan |e verfasserin |4 aut | |
| 700 | 1 | |a Hewitt, Stephen |e verfasserin |4 aut | |
| 700 | 1 | |a Horlings, Hugo M |e verfasserin |4 aut | |
| 700 | 1 | |a Husain, Zaheed |e verfasserin |4 aut | |
| 700 | 1 | |a Irshad, Sheeba |e verfasserin |4 aut | |
| 700 | 1 | |a Janssen, Emiel Am |e verfasserin |4 aut | |
| 700 | 1 | |a Kataoka, Tatsuki R |e verfasserin |4 aut | |
| 700 | 1 | |a Kawaguchi, Kosuke |e verfasserin |4 aut | |
| 700 | 1 | |a Khramtsov, Andrey I |e verfasserin |4 aut | |
| 700 | 1 | |a Kiraz, Umay |e verfasserin |4 aut | |
| 700 | 1 | |a Kirtani, Pawan |e verfasserin |4 aut | |
| 700 | 1 | |a Kodach, Liudmila L |e verfasserin |4 aut | |
| 700 | 1 | |a Korski, Konstanty |e verfasserin |4 aut | |
| 700 | 1 | |a Akturk, Guray |e verfasserin |4 aut | |
| 700 | 1 | |a Scott, Ely |e verfasserin |4 aut | |
| 700 | 1 | |a Kovács, Anikó |e verfasserin |4 aut | |
| 700 | 1 | |a Laenkholm, Anne-Vibeke |e verfasserin |4 aut | |
| 700 | 1 | |a Lang-Schwarz, Corinna |e verfasserin |4 aut | |
| 700 | 1 | |a Larsimont, Denis |e verfasserin |4 aut | |
| 700 | 1 | |a Lennerz, Jochen K |e verfasserin |4 aut | |
| 700 | 1 | |a Lerousseau, Marvin |e verfasserin |4 aut | |
| 700 | 1 | |a Li, Xiaoxian |e verfasserin |4 aut | |
| 700 | 1 | |a Madabhushi, Anant |e verfasserin |4 aut | |
| 700 | 1 | |a Maley, Sai K |e verfasserin |4 aut | |
| 700 | 1 | |a Manur Narasimhamurthy, Vidya |e verfasserin |4 aut | |
| 700 | 1 | |a Marks, Douglas K |e verfasserin |4 aut | |
| 700 | 1 | |a McDonald, Elizabeth S |e verfasserin |4 aut | |
| 700 | 1 | |a Mehrotra, Ravi |e verfasserin |4 aut | |
| 700 | 1 | |a Michiels, Stefan |e verfasserin |4 aut | |
| 700 | 1 | |a Kharidehal, Durga |e verfasserin |4 aut | |
| 700 | 1 | |a Minhas, Fayyaz Ul Amir Afsar |e verfasserin |4 aut | |
| 700 | 1 | |a Mittal, Shachi |e verfasserin |4 aut | |
| 700 | 1 | |a Moore, David A |e verfasserin |4 aut | |
| 700 | 1 | |a Mushtaq, Shamim |e verfasserin |4 aut | |
| 700 | 1 | |a Nighat, Hussain |e verfasserin |4 aut | |
| 700 | 1 | |a Papathomas, Thomas |e verfasserin |4 aut | |
| 700 | 1 | |a Penault-Llorca, Frederique |e verfasserin |4 aut | |
| 700 | 1 | |a Perera, Rashindrie D |e verfasserin |4 aut | |
| 700 | 1 | |a Pinard, Christopher J |e verfasserin |4 aut | |
| 700 | 1 | |a Pinto-Cardenas, Juan Carlos |e verfasserin |4 aut | |
| 700 | 1 | |a Pruneri, Giancarlo |e verfasserin |4 aut | |
| 700 | 1 | |a Pusztai, Lajos |e verfasserin |4 aut | |
| 700 | 1 | |a Rajpoot, Nasir Mahmood |e verfasserin |4 aut | |
| 700 | 1 | |a Rapoport, Bernardo Leon |e verfasserin |4 aut | |
| 700 | 1 | |a Rau, Tilman T |e verfasserin |4 aut | |
| 700 | 1 | |a Ribeiro, Joana M |e verfasserin |4 aut | |
| 700 | 0 | |a et al |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t The Journal of pathology |d 1969 |g 262(2024), 3 vom: 01. März, Seite 271-288 |w (DE-627)NLM000062006 |x 1096-9896 |7 nnns |
| 773 | 1 | 8 | |g volume:262 |g year:2024 |g number:3 |g day:01 |g month:03 |g pages:271-288 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1002/path.6238 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 262 |j 2024 |e 3 |b 01 |c 03 |h 271-288 | ||